Role of IgG and IgM antinuclear antibodies in formation of lupus erythematosus cells and extracellular material.
D000974:Antibodies, Antinuclear / Q000032:analysis / Q000502:physiology*; D000918:Antibody Specificity; D000937:Antigen-Antibody Reactions; D003165:Complement System Proteins / Q000502:physiology; D005455:Fluorescent Antibody Technique; D006801:Humans; D007074:Immunoglobulin G / Q000032:analysis / Q000037:antagonists & inhibitors / Q000502:physiology*; D007075:Immunoglobulin M / Q000032:analysis / Q000037:antagonists & inhibitors / Q000502:physiology*; D007136:Immunoglobulins; D008099:Liver / Q000166:cytology / Q000276:immunology; D008180:Lupus Erythematosus, Systemic / Q000276:immunology* / Q000503:physiopathology; D015122:Mercaptopurine / Q000494:pharmacology; D009504:Neutrophils; D009596:Nitrophenols / Q000494:pharmacology
D000974:Antibodies, Antinuclear; D007074:Immunoglobulin G; D007075:Immunoglobulin M; D007136:Immunoglobulins; D009596:Nitrophenols; D003165:Complement System Proteins; D015122:Mercaptopurine